Zenas BioPharma (ZBIO) Interest Coverage Ratio (2023 - 2026)
Zenas BioPharma (ZBIO) posted quarterly Interest Coverage Ratio of 1.12 for Q1 2026, up 94.35% year-over-year from 0.58 in Q1 2025, and down 15.11% quarter-over-quarter from 0.98 in Q4 2025.
Zenas BioPharma (ZBIO) Interest Coverage Ratio (2023 - 2026) Analysis & Trends
Zenas BioPharma's Interest Coverage Ratio history runs 4 years deep, the most recent figure standing at 1.12 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 94.35% year-over-year to 1.12; the TTM figure through Mar 2026 stood at 6.14 (up 93.36% YoY), while the FY2025 annual figure was 1.57, up 13.5% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 1.12, down from 0.98 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 0.16 in Q3 2024, with the low at 45.05 in Q4 2023.
- The 4-year median for Interest Coverage Ratio is 8.42 (2025), against an average of 13.74.
- Peak annual rise in Interest Coverage Ratio reached 96.31% in 2025, while the deepest fall reached 237.3% in 2025.
- Zenas BioPharma's Interest Coverage Ratio stood at 45.05 in 2023, then soared by 41.32% to 26.44 in 2024, then jumped by 96.31% to 0.98 in 2025, then dropped by 15.11% to 1.12 in 2026.
- Business Quant data shows ZBIO's Interest Coverage Ratio at 1.12 in Q1 2026, 0.98 in Q4 2025, and 0.54 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Zenas BioPharma | 1.87 Bn | 748.44 Mn | - | -0.77 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.77 |
| Mar 31, 2026 | -1.12 |
| Dec 31, 2025 | -0.98 |
| Sep 30, 2025 | -0.54 |
| Jun 30, 2025 | -15.72 |
| Mar 31, 2025 | -19.89 |
| Dec 31, 2024 | -26.44 |
| Sep 30, 2024 | -0.16 |
| Dec 31, 2023 | -45.05 |